State Street Corp Sellas Life Sciences Group, Inc. Transaction History
State Street Corp
- $2.47 Trillion
- Q4 2024
A detailed history of State Street Corp transactions in Sellas Life Sciences Group, Inc. stock. As of the latest transaction made, State Street Corp holds 227,729 shares of SLS stock, worth $275,552. This represents 0.0% of its overall portfolio holdings.
Number of Shares
227,729
Previous 174,529
30.48%
Holding current value
$275,552
Previous $218,000
5.5%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding SLS
# of Institutions
37Shares Held
6.49MCall Options Held
1.8MPut Options Held
49.7K-
Vanguard Group Inc Valley Forge, PA2.29MShares$2.77 Million0.0% of portfolio
-
Anson Funds Management LP Dallas, TX1.19MShares$1.44 Million0.16% of portfolio
-
Geode Capital Management, LLC Boston, MA734KShares$887,5900.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il485KShares$587,2330.0% of portfolio
-
Black Rock Inc. New York, NY430KShares$520,7450.0% of portfolio
About SELLAS Life Sciences Group, Inc.
- Ticker SLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,551,900
- Market Cap $24.9M
- Description
- SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...